Impact of SSTR PET on Inter-Observer Variability of Target Delineation of Meningioma and the Possibility of Using Threshold-Based Segmentations in Radiation Oncology.
Inter-observer variability
PET/CT
meningioma imaging
radiation therapy planning
somatostatin receptor PET
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
13 Sep 2022
13 Sep 2022
Historique:
received:
10
05
2022
revised:
31
08
2022
accepted:
08
09
2022
entrez:
23
9
2022
pubmed:
24
9
2022
medline:
24
9
2022
Statut:
epublish
Résumé
Aim: The aim of this study was to assess the effects of including somatostatin receptor agonist (SSTR) PET imaging in meningioma radiotherapy planning by means of changes in inter-observer variability (IOV). Further, the possibility of using threshold-based delineation approaches for semiautomatic tumor volume definition was assessed. Patients and Methods: Sixteen patients with meningioma undergoing fractionated radiotherapy were delineated by five radiation oncologists. IOV was calculated by comparing each delineation to a consensus delineation, based on the simultaneous truth and performance level estimation (STAPLE) algorithm. The consensus delineation was used to adapt a threshold-based delineation, based on a maximization of the mean Dice coefficient. To test the threshold-based approach, seven patients with SSTR-positive meningioma were additionally evaluated as a validation group. Results: The average Dice coefficients for delineations based on MRI alone was 0.84 ± 0.12. For delineation based on MRI + PET, a significantly higher dice coefficient of 0.87 ± 0.08 was found (p < 0.001). The Hausdorff distance decreased from 10.96 ± 11.98 mm to 8.83 ± 12.21 mm (p < 0.001) when adding PET for the lesion delineation. The best threshold value for a threshold-based delineation was found to be 14.0% of the SUVmax, with an average Dice coefficient of 0.50 ± 0.19 compared to the consensus delineation. In the validation cohort, a Dice coefficient of 0.56 ± 0.29 and a Hausdorff coefficient of 27.15 ± 21.54 mm were found for the threshold-based approach. Conclusions: SSTR-PET added to standard imaging with CT and MRI reduces the IOV in radiotherapy planning for patients with meningioma. When using a threshold-based approach for PET-based delineation of meningioma, a relatively low threshold of 14.0% of the SUVmax was found to provide the best agreement with a consensus delineation.
Identifiants
pubmed: 36139596
pii: cancers14184435
doi: 10.3390/cancers14184435
pmc: PMC9497299
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Lancet Oncol. 2016 Sep;17(9):e383-91
pubmed: 27599143
IEEE Trans Med Imaging. 2004 Jul;23(7):903-21
pubmed: 15250643
J Med Imaging Radiat Oncol. 2016 Jun;60(3):393-406
pubmed: 27170216
J Nucl Med. 2017 Oct;58(10):1580-1587
pubmed: 28450556
Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):222-7
pubmed: 16488553
PLoS One. 2018 Apr 13;13(4):e0195798
pubmed: 29652908
Acta Neuropathol. 2015 Sep;130(3):441-3
pubmed: 26195322
Clin Oncol (R Coll Radiol). 2017 Jul;29(7):448-458
pubmed: 28433399
Eur J Nucl Med Mol Imaging. 2016 May;43(5):911-924
pubmed: 26567163
Int J Cancer. 1998 May 29;76(5):620-7
pubmed: 9610716
Radiat Oncol. 2018 Nov 12;13(1):219
pubmed: 30419929
Nuklearmedizin. 2013;52(1):28-35
pubmed: 23348719
Int J Mol Imaging. 2013;2013:980769
pubmed: 23533750
Eur J Nucl Med Mol Imaging. 2012 Sep;39(9):1409-15
pubmed: 22669255
Cancers (Basel). 2021 Sep 20;13(18):
pubmed: 34572933
Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):310-8
pubmed: 19763565
J Nucl Med. 2001 Jul;42(7):1053-6
pubmed: 11438627
Neuro Oncol. 2019 Nov 1;21(Suppl 5):v1-v100
pubmed: 31675094
J Nucl Med. 2015 Mar;56(3):347-53
pubmed: 25635133
Int J Radiat Oncol Biol Phys. 2022 Jul 15;113(4):859-865
pubmed: 35460804
Radiat Oncol. 2009 Nov 18;4:56
pubmed: 19922642
EJNMMI Phys. 2021 Feb 27;8(1):21
pubmed: 33638729